Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02953457
Brief Title: Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation

First Submitted : November 1, 2016
First Submitted that Met QC Criteria : November 1, 2016
First Posted : November 2, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 29, 2021
Last Update Posted : February 2, 2021